The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 2,458 | 960,000 | SH | SOLE | 960,000 | 0 | 0 | ||
AMARIN CORP PLC | SPONSORED ADR | 023111206 | 3,149 | 455,000 | SH | SOLE | 455,000 | 0 | 0 | ||
APTOSE BIOSCIENCES INC | COM NEW | 03835T200 | 19,750 | 3,130,000 | SH | SOLE | 3,130,000 | 0 | 0 | ||
ARDELYX INC | COM | 039697107 | 3,263 | 471,600 | SH | SOLE | 471,600 | 0 | 0 | ||
ASSERTIO HOLDINGS INC | COM | 04546C106 | 754 | 880,000 | SH | SOLE | 880,000 | 0 | 0 | ||
AUTOLUS THERAPEUTICS PLC | SPONSORED ADS | 05280R100 | 962 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
AVENUE THERAPEUTICS INC | COM NEW | 05360L205 | 11,147 | 1,035,000 | SH | SOLE | 1,035,000 | 0 | 0 | ||
BIOHAVEN PHARMACEUTICAL HLDG | COM | G11196105 | 8,360 | 114,350 | SH | SOLE | 114,350 | 0 | 0 | ||
BIOLINERX LTD | SPONSORED ADS | 09071M205 | 29 | 16,667 | SH | SOLE | 16,667 | 0 | 0 | ||
BIOXCEL THERAPEUTICS INC | COM | 09075P105 | 4,983 | 94,000 | SH | SOLE | 94,000 | 0 | 0 | ||
CARDIFF ONCOLOGY INC | COM | 14147L108 | 2,956 | 590,000 | SH | SOLE | 590,000 | 0 | 0 | ||
CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 5,336 | 1,155,000 | SH | SOLE | 1,155,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | 13,923 | 1,071,000 | SH | SOLE | 1,071,000 | 0 | 0 | ||
CERECOR INC | COM | 15671L109 | 8,768 | 3,372,500 | SH | SOLE | 3,372,500 | 0 | 0 | ||
CHEMOCENTRYX INC | COM | 16383L106 | 20,816 | 361,600 | SH | SOLE | 361,600 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 6,526 | 2,105,000 | SH | SOLE | 2,105,000 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757107 | 3,582 | 970,664 | SH | SOLE | 970,664 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 16,089 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS INC | COM | 22663K107 | 7,625 | 435,200 | SH | SOLE | 435,200 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 7,143 | 303,050 | SH | SOLE | 303,050 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 13,081 | 222,000 | SH | SOLE | 222,000 | 0 | 0 | ||
EDAP TMS SA | SPONSORED ADR | 268311107 | 4,648 | 1,878,500 | SH | SOLE | 1,878,500 | 0 | 0 | ||
EIDOS THERAPEUTICS INC | COM | 28249H104 | 14,634 | 315,550 | SH | SOLE | 315,550 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 1,085 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
ETON PHARMACEUTICALS INC | COM | 29772L108 | 19,838 | 3,640,000 | SH | SOLE | 3,640,000 | 0 | 0 | ||
FENNEC PHARMACEUTICALS INC | COM | 31447P100 | 1,428 | 171,000 | SH | SOLE | 171,000 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 5,688 | 146,000 | SH | SOLE | 146,000 | 0 | 0 | ||
FORTRESS BIOTECH INC | COM | 34960Q109 | 10,264 | 3,830,000 | SH | SOLE | 3,830,000 | 0 | 0 | ||
HARROW HEALTH INC | COM | 415858109 | 14,119 | 2,710,000 | SH | SOLE | 2,710,000 | 0 | 0 | ||
KALA PHARMACEUTICALS INC | COM | 483119103 | 3,794 | 361,000 | SH | SOLE | 361,000 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 5,584 | 461,500 | SH | SOLE | 461,500 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 8,778 | 344,500 | SH | SOLE | 344,500 | 0 | 0 | ||
LIQUIDIA TECHOLOGIES INC | COM | 53635D202 | 3,368 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 13,988 | 501,000 | SH | SOLE | 501,000 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 385 | 51,225 | SH | SOLE | 51,225 | 0 | 0 | ||
MEI PHARMA INC | COM NEW | 55279B202 | 6,426 | 1,556,000 | SH | SOLE | 1,556,000 | 0 | 0 | ||
MOLECULAR TEMPLATES INC | COM | 608550109 | 6,826 | 495,000 | SH | SOLE | 495,000 | 0 | 0 | ||
MYOVANT SCIENCES LTD | COM | G637AM102 | 14,073 | 682,500 | SH | SOLE | 682,500 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 23,240 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 49,848 | 5,984,200 | SH | SOLE | 5,984,200 | 0 | 0 | ||
ODONATE THERAPEUTICS INC | COM | 676079106 | 10,585 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 64,752 | 2,208,472 | SH | SOLE | 2,208,472 | 0 | 0 | ||
STEREOTAXIS INC | COM NEW | 85916J409 | 15,661 | 3,511,500 | SH | SOLE | 3,511,500 | 0 | 0 | ||
TELA BIO INC | COM | 872381108 | 3,240 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 8,895 | 456,600 | SH | SOLE | 456,600 | 0 | 0 | ||
TRICIDA INC | COM | 89610F101 | 6,548 | 238,300 | SH | SOLE | 238,300 | 0 | 0 | ||
VAXCYTE | SHS | N90064101 | 8,547 | 270,400 | SH | SOLE | 270,400 | 0 | 0 | ||
XOMA CORP DEL | COM NEW | 98419J206 | 8,208 | 415,380 | SH | SOLE | 415,380 | 0 | 0 |